# A systematic review and economic model of the effectiveness and cost-effectiveness of methylphenidate, dexamfetamine and atomoxetine for the treatment of attention deficit hyperactivity disorder in children and adolescents

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/a-systematic-review-and-economic-model-of-the-effectiveness-and-cost/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Sarah King,Susan Griffin,Z. Hodges,Helen Weatherly,Christian Asseburg,Gerry Richardson,Su Golder,E. Taylor,Murray Drummond,R.P. Riemsma |
| Citations | 186 |
| DOI | 10.3310/hta10230 |
| Fields | Medicine,Neuroscience |
| Open Access | true |
| OA Status | diamond |
| OA URL | https://njl-admin.nihr.ac.uk/document/download/2001321 |
| OpenAlex ID | https://openalex.org/W2165990772 |
| PMID | 16796929 |
| Type | review |
| Year | 2006 |

## Paper authors

- [Christian Asseburg](https://scholariq.org/researchers/christian-asseburg/)

## Paper journal

- [Health Technology Assessment](https://scholariq.org/journals/health-technology-assessment/)

## Paper primary topic

- [Attention Deficit Hyperactivity Disorder](https://scholariq.org/topics/attention-deficit-hyperactivity-disorder/)

## Paper topics

- [Attention Deficit Hyperactivity Disorder](https://scholariq.org/topics/attention-deficit-hyperactivity-disorder/)
- [Bipolar Disorder and Treatment](https://scholariq.org/topics/bipolar-disorder-and-treatment/)
- [Autism Spectrum Disorder Research](https://scholariq.org/topics/autism-spectrum-disorder-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.